1zt5: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
|PDB= 1zt5 |SIZE=350|CAPTION= <scene name='initialview01'>1zt5</scene>, resolution 1.818Å | |PDB= 1zt5 |SIZE=350|CAPTION= <scene name='initialview01'>1zt5</scene>, resolution 1.818Å | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand= | |LIGAND= <scene name='pdbligand=DIO:1,4-DIETHYLENE+DIOXIDE'>DIO</scene>, <scene name='pdbligand=FE2:FE+(II)+ION'>FE2</scene> | ||
|ACTIVITY= | |ACTIVITY= | ||
|GENE= | |GENE= | ||
|DOMAIN= | |||
|RELATEDENTRY=[[1zt3|1ZT3]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1zt5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1zt5 OCA], [http://www.ebi.ac.uk/pdbsum/1zt5 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1zt5 RCSB]</span> | |||
}} | }} | ||
| Line 35: | Line 38: | ||
[[Category: Valli, M.]] | [[Category: Valli, M.]] | ||
[[Category: Visai, L.]] | [[Category: Visai, L.]] | ||
[[Category: amniotic fluid]] | [[Category: amniotic fluid]] | ||
[[Category: c-terminal domain]] | [[Category: c-terminal domain]] | ||
| Line 44: | Line 45: | ||
[[Category: metal-binding]] | [[Category: metal-binding]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 01:41:17 2008'' | ||
Revision as of 01:41, 31 March 2008
| |||||||
| , resolution 1.818Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | , | ||||||
| Related: | 1ZT3
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
C-terminal domain of Insulin-like Growth Factor Binding Protein-1 isolated from human amniotic fluid complexed with Iron(II)
OverviewOverview
Insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) regulates the activity of the insulin-like growth factors in early pregnancy and is, thus, thought to play a key role at the fetal-maternal interface. The C-terminal domain of IGFBP-1 and three isoforms of the intact protein were isolated from human amniotic fluid, and sequencing of the four N-terminal polypeptide chains showed them to be highly pure. The addition of both intact IGFBP-1 and its C-terminal fragment to cultured fibroblasts has a similar stimulating effect on cell migration, and therefore, the domain has a biological activity on its own. The three-dimensional structure of the C-terminal domain was determined by x-ray crystallography to 1.8 Angstroms resolution. The fragment folds as a thyroglobulin type I domain and was found to bind the Fe(2+) ion in the crystals through the only histidine residue present in the polypeptide chain. Iron (II) decreases the binding of intact IGFBP-1 and the C-terminal domain to IGF-II, suggesting that the metal binding site is close to or part of the surface of interaction of the two molecules.
About this StructureAbout this Structure
1ZT5 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid., Sala A, Capaldi S, Campagnoli M, Faggion B, Labo S, Perduca M, Romano A, Carrizo ME, Valli M, Visai L, Minchiotti L, Galliano M, Monaco HL, J Biol Chem. 2005 Aug 19;280(33):29812-9. Epub 2005 Jun 22. PMID:15972819
Page seeded by OCA on Mon Mar 31 01:41:17 2008